🇨🇦 mOPV2 at 6 and 10 weeks of age in Canada

mOPV2 at 6 and 10 weeks of age (mOPV2 at 6 and 10 weeks of age) regulatory status in Canada.

Marketing authorisation

mOPV2 at 6 and 10 weeks of age in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is mOPV2 at 6 and 10 weeks of age approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for mOPV2 at 6 and 10 weeks of age in Canada?

Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.